Back

Right ventricular to pulmonary artery uncoupling predicts adverse cardiovascular events in adult patients with right-sided congenital heart diseases.

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Valvular heart disease 3 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Giulia Iannaccone

Catholic University of the Sacred Heart, Rome (Italy)

7 More presentations in this session

Presentation thumbnail
Exercise-induced tricuspid regurgitation in heart failure, gas exchange profile and outcomes
Doctor G. Mondellini (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Geometry of tricuspid annulus in functional tricuspid regurgitation patients: differences between aetiologies. 3D echocardiography study
Mr D. Verikas (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
Aortic stenosis and progression of left ventricular dysfunction
Doctor I. Rodrigues (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Gender differences in left ventricular systolic function among patients with severe aortic stenosis
Mr A. De Oliveira Carvalho dos Santos (Aveiro, PT)
Abstract Slides Video
Presentation thumbnail
Prevalence and incidence of diastolic dysfunction in moderate aortic stenosis: clinical implication
Doctor R. Teixeira (Vila Nova de Gaia, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular heart disease 3

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Baseline right ventricular-pulmonary artery uncoupling and mortality following transcatheter aortic valve replacement: a meta-analysis
thumbnail
Congress Presentation
Right ventricular-pulmonary artery coupling as an indicator of clinical outcomes in patients undergoing transcatheter tricuspid annuloplasty
thumbnail
Congress Presentation
Right ventricular to pulmonary artery uncoupling is an early predictor of poor outcome in wild-type transthyretin cardiac amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources